State Of New Jersey Common Pension Fund D Geron Corp Transaction History

State Of New Jersey Common Pension Fund D

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 23, 2019	SELL	$1.15 - $1.59 $580,750 - $802,950	-505,000 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$1.76 - $6.38 $642,400 - $2.33 Million	-365,000 Reduced 41.95%	505,000 $889,000
Q3 2017 Oct 25, 2017	BUY	$1.99 - $2.65 $1.73 Million - $2.31 Million	870,000	870,000 $1.9 Million

259

450M

1.91M

897K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.59B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.